Publications by authors named "Peter Reichardt"

100Publications

Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtype.

Expert Rev Anticancer Ther 2020 04 30;20(sup1):15-28. Epub 2020 Apr 30.

Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

View Article and Find Full Text PDF
April 2020

Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.

Lancet Oncol 2019 12 6;20(12):1719-1729. Epub 2019 Nov 6.

Chemotherapy Unit, IRCCS Istituto Ortopedico Rizzoli/Department of Experimental, Diagnostic and Specialty Medicine, Università di Bologna, Bologna, Italy. Electronic address:

View Article and Find Full Text PDF
December 2019

Foreword.

Authors:
Peter Reichardt

Future Oncol 2019 09 10;15(26s):1-3. Epub 2019 Sep 10.

Department of Oncology & Palliative Care, Helios Klinikum Berlin-Buch, Berlin, 13125 Berlin, Germany.

View Article and Find Full Text PDF
September 2019

Malignancy in Giant Cell Tumor of Bone: A Review of the Literature.

Technol Cancer Res Treat 2019 01;18:1533033819840000

4 Biostatistics, Amgen Ltd, Cambridge, United Kingdom.

View Article and Find Full Text PDF
January 2019

Filamin A Phosphorylation at Serine 2152 by the Serine/Threonine Kinase Ndr2 Controls TCR-Induced LFA-1 Activation in T Cells.

Front Immunol 2018 4;9:2852. Epub 2018 Dec 4.

Institute of Molecular and Clinical Immunology, Health Campus Immunology, Infectiology and Inflammation (GC-I3), Otto-von-Guericke-University, Magdeburg, Germany.

View Article and Find Full Text PDF
October 2019

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.

J Clin Oncol 2018 Sep 6:JCO2018782516. Epub 2018 Sep 6.

Jeremy Whelan, University College Hospital; Ian Judson, Institute of Cancer Research, London; Bernadette Brennan, Royal Manchester Children's Hospital, Manchester; Bruce Morland, Birmingham Children's Hospital; Keith Wheatley, University of Birmingham, Birmingham; Ian Lewis, Leeds Community Healthcare National Health Service Trust, Leeds; Alan Craft, Newcastle University, Newcastle upon Tyne, United Kingdom; Marie-Cecile Le Deley and Cyril Lervat, Centre Oscar Lambret, Lille; Gwénaël Le Teuff, Nathalie Gaspar, and Odile Oberlin, Institut Gustave Roussy, Villejuif; Jean-Yves Blay, Centre Léon Bérard; Perrine Marec-Berard, Institute of Pediatric Onco-Haematology, Lyon; Marie-Pierre Castex, Centre Hospitalier Universitaire de Toulouse, Toulouse; Jean-Claude Gentet, Centre Hospitalier Universitaire La Timone, Marseille; Marta Jimenez, Unicancer; Valerie Laurence and Jean Michon, Institut Curie, Paris; France; Uta Dirksen, Sebastian Bauer, Andreas Ranft, University Hospital Essen, Essen; Susanne Amler, Institut für Biometrie und Klinische Forschung; Wolfgang Hartmann and Heribert Juergens, Universitätsklinikum, Münster, Münster; Stefan Bielack, Klinikum Stuttgart, Stuttgart; Stefan Burdach, Comprehensive Cancer Center, München; Dagmar Dilloo, University-Clinic Bonn, Bonn; Angelika Eggert, Charité University; Peter Reichardt, HELIOS Klinikum Berlin-Buch, Berlin; Wolf-Achim Hassenpflug, University Medical Center Hamburg-Eppendorf, Hamburg; Thomas Klingebiel, Childrens University Hospital, Frankfurt; Udo Kontny, University Medical Center Aachen, Aachen; Michael Paulussen, Children's and Adolescents' Hospital, Datteln; Germany; Douglas S. Hawkins, Seattle Children's Hospital, Seattle, WA; Hans Gelderblom, Leiden University Medical Center, Leiden; Hendrik van den Berg, University of Amsterdam, Amsterdam, the Netherlands; Lars Hjorth, Skane University Hospital, Lund, Sweden; Jarmila Kruseova, Faculty Hospital Motol Prague, Prague, Czech Republic; Ruth Ladenstein, St Anna Children's Hospital and Children's Cancer Research Institute, Vienna, Austria; Sandrine Marreaud, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.

View Article and Find Full Text PDF
September 2018

Options for treating different soft tissue sarcoma subtypes.

Future Oncol 2018 May;14(10s):25-49

Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University of Duisburg-Essen, Essen, Germany.

View Article and Find Full Text PDF
May 2018

Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling.

Future Oncol 2018 Oct 11;14(25):2663-2676. Epub 2018 May 11.

Division of Clinical Studies, Institute of Cancer Research & Sarcoma Unit of the Royal Marsden NHS Foundation Trust, London, UK.

View Article and Find Full Text PDF
October 2018

Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy.

ESC Heart Fail 2018 08 19;5(4):620-629. Epub 2018 Apr 19.

Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center - a joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany.

View Article and Find Full Text PDF
August 2018

Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer.

Gynecol Oncol 2018 07 5;150(1):173-179. Epub 2018 Apr 5.

Christie Hospital and Institute of Cancer Studies, University of Manchester, Manchester, UK. Electronic address:

View Article and Find Full Text PDF
July 2018

Review of past and present clinical cases with a view to future treatment options.

Future Oncol 2017 Jun 2;13(13s):11-28. Epub 2017 May 2.

Department of Medical Oncology, Centre Leon Berard, Lyon, France.

View Article and Find Full Text PDF
June 2017

Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trial.

Pediatr Blood Cancer 2017 Oct 24;64(10). Epub 2017 Apr 24.

Department of Pediatric Hematology and Oncology, University Hospital Muenster, Westfalian Wilhelms University, Muenster, Germany.

View Article and Find Full Text PDF
October 2017

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.

J Clin Oncol 2017 May 31;35(15):1713-1720. Epub 2017 Mar 31.

Paolo G. Casali, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori and University of Milan; Elena Fumagalli and Alessandro Gronchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milano, Italy; John Zalcberg, Peter MacCallum Cancer Institute, East Melbourne, Victoria; Dusan Kotasek, Adelaide Cancer Centre, Kurralta Park and University of Adelaide, South Australia, Australia; Axel Le Cesne, Gustave Roussy, Villejuif; Jean-Yves Blay, NetSARC and Site de Recherche Intégrée sur le Cancer de Lyon, Centre Leon Berard, Lyon; Antoine Italiano, Institut Bergonie, Bordeaux, France; Peter Reichardt, HELIOS Klinikum Berlin-Buch, Berlin; Lars H. Lindner, Klinikum der Universitaet München, München; Viktor Grünwald, School Hannover, Hannover, Germany; Ian R. Judson and Winette van der Graaf, Royal Marsden Hospital, London, United Kingdom; Patrick Schöffski, Universitaire Ziekenhuizen Leuven, Campus Gasthuisberg, Leuven; Saskia Litière and Sandrine Marreaud, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Serge Leyvraz, University Hospital, Lausanne, Switzerland; Antonio Lopez Pousa, Hospital De La Santa Creu I Sant Pau, Barcelona, Spain; Stefan Sleijfer and Jaap Verweij, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam; Jan M. Kerst, The Netherlands Cancer Institute, Amsterdam; Pancras Hogendoorn, Leiden University Medical Center, Leiden; Winette van der Graaf, Radboud University, Medical Center Nijmegen, the Netherlands; and Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.

View Article and Find Full Text PDF
May 2017

SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour.

Br J Cancer 2017 Apr 23;116(9):1195-1202. Epub 2017 Mar 23.

Laboratory of Molecular Oncology, Translational Cancer Biology Research Program, Department of Oncology, University of Helsinki, P.O Box 63, FI-00014 University of Helsinki, Helsinki, Finland.

View Article and Find Full Text PDF
April 2017

Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).

Eur J Cancer 2017 05 8;76:60-67. Epub 2017 Mar 8.

University of Heidelberg, Mannheim University Medical Center, Interdisciplinary Tumor Center Mannheim, Sarcoma Unit, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany; University of Heidelberg, Mannheim University Medical Center, Division of Surgical Oncology, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.

View Article and Find Full Text PDF
May 2017

The importance of treating by histological subtype in advanced soft tissue sarcoma.

Future Oncol 2017 Jan;13(1s):23-31

Sarcoma Center Berlin-Brandenburg, HELIOS Klinikum Berlin-Buch, Berlin, Germany.

View Article and Find Full Text PDF
January 2017

Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.

Int J Hyperthermia 2016 15;32(2):159-64. Epub 2015 Dec 15.

b Department of Orthopaedic Oncology , Sarcoma Centre Berlin-Brandenburg, HELIOS Klinikum Berlin-Buch , Berlin , Germany .

View Article and Find Full Text PDF
January 2017

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

J Clin Oncol 2016 Jan 2;34(3):244-50. Epub 2015 Nov 2.

Heikki Joensuu and Petri Bono, Comprehensive Cancer Center Helsinki; Heikki Joensuu, Harri Sihto, and Petri Bono, University of Helsinki, Helsinki; Raija Kallio, Oulu University Hospital, Oulu; Jouni Junnila, 4Pharma, Turku, Finland; Mikael Eriksson and Thor Alvegård, Lund University, Lund; Bengt Nilsson, Sahlgrenska University Hospital, Gothenburg, Sweden; Kirsten Sundby Hall, Oslo University Hospital, Oslo, Norway; Annette Reichardt, Daniel Pink, and Peter Reichardt, Sarkomzentrum Berlin-Brandenburg, HELIOS Klinikum Berlin-Buch, Berlin; Jörg T. Hartmann, Franziskus Hospital, Catholic Hospital Consortium Ostwestfalen, Bielefeld; Giuliano Ramadori, University of Göttingen, Göttingen; Peter Hohenberger, Mannheim University Medical Center, Mannheim; Salah-Eddin Al-Batran, Klinik für Onkologie und Hämatologie am Krankenhaus Nordwest, Frankfurt; Marcus Schlemmer, University Hospital Großhadern, Ludwig Maximilians University, Munich; Sebastian Bauer, Sarcoma Center, West German Cancer Center, Essen; and Eva Wardelmann, Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Münster, Germany.

View Article and Find Full Text PDF
January 2016

Key Issues in the Clinical Management of Gastrointestinal Stromal Tumors: An Expert Discussion.

Oncologist 2015 Jul 12;20(7):823-30. Epub 2015 Jun 12.

Tisch Cancer Institute, Mount Sinai Medical Center, New York, New York, USA; Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA; Helsinki University Hospital and University of Helsinki, Helsinki, Finland; Servicio de Oncología Médica, Fundación Instituto Valenciano de Oncología, Valencia, Spain; National Cancer Center Hospital East, Department of Surgery, Kashiwa, Japan; HELIOS Klinikum Berlin-Buch, Interdisciplinary Oncology, Berlin, Germany; General Medical Oncology, Leuven Cancer Institute, University Hospital Gasthuisberg, Catholic University Leuven, Leuven, Belgium; University of Miami Sylvester Cancer Center, Sarcoma Medical Oncology Program, Miami, Florida, USA.

View Article and Find Full Text PDF
July 2015

Trabectedin clinical cases: use according to indication in diverse clinical scenarios.

Future Oncol 2015 ;11(11 Suppl):15-24

4Department of Interdisciplinary Oncology, HELIOS Klinikum Berlin-Buch, Berlin, Germany.

View Article and Find Full Text PDF
February 2016

Optimizing the use of trabectedin for advanced soft tissue sarcoma in daily clinical practice.

Future Oncol 2015 ;11(11 Suppl):3-14

2Department of Interdisciplinary Oncology, HELIOS Klinikum Berlin-Buch, Berlin, Germany.

View Article and Find Full Text PDF
February 2016

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

J Clin Oncol 2015 Jul 1;33(20):2279-87. Epub 2015 Jun 1.

Stefan S. Bielack, Klinikum Stuttgart-Olgahospital, Stuttgart; Mathias Werner, Helios Klinikum Emil von Behring; Per-Ulf Tunn, Helios Klinikum Berlin-Buch, Berlin; Knut Helmke, Altonaer Kinderkrankenhaus, Hamburg; Heribert Jürgens, Gabriele Calaminus, Joachim Gerss, and Trude Butterfass-Bahloul, Universitätsklinikum Münster, Münster; Peter Reichardt, Klinik für Interdisziplinäre Onkologie, Bad Saarow, Germany; Sigbjørn Smeland and Kirsten Sundby Hall, Oslo University Hospital; Kirsten Sundby Hall, Norwegian Radium Hospital, Oslo, Norway; Jeremy S. Whelan, University College London Hospitals; Gordana Jovic, Jane M. Hook, and Matthew R. Sydes, University College London; Beatrice Seddon and Maria Michelagnoli, University College Hospital, London; Bernadette Brennan, Christie Hospital and Royal Manchester Children's Hospital, Manchester; Susan Picton, Leeds University Hospital, Leeds, United Kingdom; Neyssa Marina, Stanford University Medical Center; Claudia Deffenbaugh, Lucille Salter Packard Children's Hospital, Palo Alto; Mark D. Krailo, Children's Oncology Group, Arcadia, CA; Mark Gebhardt and Allen Goorin, Dana-Farber Cancer Institute; Mark Gebhardt and Lisa A. Teot, Children's Hospital Boston, Boston, MA; Zsuzsanna Pápai, National Medical Center, Budapest, Hungary; James Meyer, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Helen Nadel, British Columbia Children's Hospital and University of British Columbia, Vancouver, British Columbia; Mark Bernstein, Dalhousie University, Halifax, Nova Scotia, Canada; R. Lor Randall, University of Utah, Salt Lake City, UT; Rajaram Nagarajan, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; G. Douglas Letson, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL; Daniel Baumhoer, Universitätsspital Basel; Thomas Kühne, University Children's Hospital Basel, Basel, Switzerland; Leo Kager, St Anna's Children Hospital; Reinhard Windhager, Medica

View Article and Find Full Text PDF
July 2015

Management of Gastrointestinal Stromal Tumour: Current Practices and Visions for the Future.

Oncology 2015 26;89(1):1-13. Epub 2015 Feb 26.

Centre Léon Bérard, Université Claude Bernard, Lyon, France.

View Article and Find Full Text PDF
September 2015

Combination of trabectedin and gemcitabine for advanced soft tissue sarcomas: results of a phase I dose escalating trial of the German Interdisciplinary Sarcoma Group (GISG).

Mar Drugs 2015 Jan 13;13(1):379-88. Epub 2015 Jan 13.

University of Heidelberg, Mannheim University Medical Center, Interdisciplinary Tumor Center Mannheim, Sarcoma Unit, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.

View Article and Find Full Text PDF
January 2015

Soft tissue sarcomas, a look into the future: different treatments for different subtypes.

Authors:
Peter Reichardt

Future Oncol 2014 Jun;10(8 Suppl):s19-27

HELIOS Klinikum Berlin-Buch, Department of Interdisciplinary Oncology, Schwanebecker Chaussee 50, 13125 Berlin, Germany.

View Article and Find Full Text PDF
June 2014

Gemcitabine and docetaxel for epithelioid sarcoma: results from a retrospective, multi-institutional analysis.

Oncology 2014 4;87(2):95-103. Epub 2014 Jul 4.

Department of Interdisciplinary Oncology, Sarcoma Center Berlin-Brandenburg, HELIOS Klinikum Berlin-Buch, Berlin, Germany.

View Article and Find Full Text PDF
September 2014

αPIX RhoGEF supports positive selection by restraining migration and promoting arrest of thymocytes.

J Immunol 2014 Apr 3;192(7):3228-38. Epub 2014 Mar 3.

Department of Functional Genomics and Medical Toponomics, Otto-von-Guericke-University, Medical Faculty, Magdeburg 39120, Germany;

View Article and Find Full Text PDF
April 2014

In vivo visualization of uterine mast cells by two-photon microscopy.

Reproduction 2014 Jun 17;147(6):781-8. Epub 2014 Feb 17.

Experimental Obstetrics and GynecologyMedical Faculty, Otto-von-Guericke University Magdeburg, Gerhart-Hauptmann-Street 35, 39108 Magdeburg, GermanyProject Group NeuropharmacologyLeibniz Institute for Neurobiology, 39118 Magdeburg, GermanyInstitute for Molecular and Clinical ImmunologyOtto-von-Guericke University Magdeburg, 39120 Magdeburg, GermanyMedical Faculty 'Carl Gustav Carus'Institute of Immunology, 01307 Dresden, GermanyInstituto Gulbenkian de CiênciasOeiras, Portugal

View Article and Find Full Text PDF
June 2014

Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan.

Eur J Nucl Med Mol Imaging 2014 Jun 12;41(6):1076-83. Epub 2014 Feb 12.

Department of General Orthopedics and Tumor Orthopedics, Münster University Hospital, Albert-Schweitzer-Campus 1, 48149, Münster, Germany,

View Article and Find Full Text PDF
June 2014

Gastrointestinal stromal tumor: a method for optimizing the timing of CT scans in the follow-up of cancer patients.

Radiology 2014 Apr 18;271(1):96-103. Epub 2013 Nov 18.

From the Department of Oncology, Helsinki University Central Hospital, Haartmaninkatu 4, PO Box 180, FIN-00029 Helsinki, Finland (H.J.); Sarkomzentrum Berlin-Brandenburg, HELIOS Klinikum Berlin-Buch, Berlin, Germany (P.R.); Department of Oncology, Skåne University Hospital, Lund University, Lund, Sweden (M.E.); Department of Oncology, the Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway (K.S.H.); and Department of Biomedical Engineering and Computational Science, Aalto University, Espoo, Finland (A.V.).

View Article and Find Full Text PDF
April 2014

T cell-independent modulation of experimental autoimmune encephalomyelitis in ADAP-deficient mice.

J Immunol 2013 Nov 7;191(10):4950-9. Epub 2013 Oct 7.

Institute of Molecular and Clinical Immunology, Otto von Guericke University, 39120 Magdeburg, Germany;

View Article and Find Full Text PDF
November 2013

Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testing.

Am J Surg Pathol 2013 Nov;37(11):1648-59

*Institute of Pathology, University of Cologne Medical Center, Cologne †Gerhard-Domagk-Institute of Pathology, University of Münster Medical Center, Münster ‡Department of General and Abdominal Surgery, University of Mainz Medical Center, Mainz §Division of Surgical Oncology and Thoracic Surgery, University of Mannheim Medical Center, Mannheim ∥Department of Hematology, Oncology and Palliative Care, Sarcoma Center Berlin-Brandenburg, HELIOS Klinikum Bad Saarow, Bad Saarow, Germany.

View Article and Find Full Text PDF
November 2013

PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical Problems.

Case Rep Oncol Med 2013 1;2013:793927. Epub 2013 Jul 1.

Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University at Dresden, Fetscherstraße 74, 01307 Dresden, Germany.

View Article and Find Full Text PDF
August 2013

New fronts in the adjuvant treatment of GIST.

Cancer Chemother Pharmacol 2013 Oct 11;72(4):715-23. Epub 2013 Aug 11.

Department of Hematology, Oncology and Palliative Medicine, HELIOS Klinikum Bad Saarow, Pieskower Strasse 33, 15526, Bad Saarow, Germany,

View Article and Find Full Text PDF
October 2013

Transiently reduced PI3K/Akt activity drives the development of regulatory function in antigen-stimulated Naïve T-cells.

PLoS One 2013 11;8(7):e68378. Epub 2013 Jul 11.

University Duisburg-Essen, University Hospital, Institute for Experimental Immunology and Imaging, Essen, Germany.

View Article and Find Full Text PDF
April 2014

Control of uterine microenvironment by foxp3(+) cells facilitates embryo implantation.

Front Immunol 2013 20;4:158. Epub 2013 Jun 20.

Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University Magdeburg , Magdeburg , Germany ; PDBEB, Center for Neuroscience and Cell Biology, University of Coimbra , Coimbra , Portugal.

View Article and Find Full Text PDF
June 2013

Multimolecular analysis of stable immunological synapses reveals sustained recruitment and sequential assembly of signaling clusters.

Mol Cell Proteomics 2013 Sep 10;12(9):2551-67. Epub 2013 Jun 10.

Otto von Guericke University, Institute of Molecular and Clinical Immunology, Leipziger Str. 44, 39120 Magdeburg, Germany.

View Article and Find Full Text PDF
September 2013

Current questions in soft tissue sarcoma: further steps with Yondelis®.

Authors:
Peter Reichardt

Expert Rev Anticancer Ther 2013 Jun;13(6 Suppl 1):25-30

HELIOS Klinikum Berlin-Buch, Department of Interdisciplinary Oncology, Schwanebecker Chaussee 50, 13125 Berlin, Germany.

View Article and Find Full Text PDF
June 2013

A role for LFA-1 in delaying T-lymphocyte egress from lymph nodes.

EMBO J 2013 Mar 26;32(6):829-43. Epub 2013 Feb 26.

Institute of Molecular and Clinical Immunology, Otto von Guericke University Magdeburg, Magdeburg, Germany.

View Article and Find Full Text PDF
March 2013

Analysis of TCR activation kinetics in primary human T cells upon focal or soluble stimulation.

J Immunol Methods 2013 Jan 22;387(1-2):276-83. Epub 2012 Nov 22.

Otto-von-Guericke University, Institute of Molecular and Clinical Immunology, Leipziger Str 44, 39120 Magdeburg, Germany.

View Article and Find Full Text PDF
January 2013

Efficacy of trabectedin in patients with advanced or metastatic alveolar soft-part sarcoma.

Onkologie 2012 23;35(5):249-52. Epub 2012 Apr 23.

HELIOS Klinikum Bad Saarow, Department of Hematology, Oncology, and Palliative Care, Sarcoma Center Berlin-Brandenburg, Bad Saarow, Germany.

View Article and Find Full Text PDF
January 2013

Gastrointestinal stromal tumors: evolving role of the multidisciplinary team approach in management.

Expert Rev Anticancer Ther 2012 Aug 14;12(8):1053-68. Epub 2012 May 14.

HELIOS Klinikum Bad Saarow GmbH, Germany.

View Article and Find Full Text PDF
August 2012

Molecular targeted therapy of gastrointestinal stromal tumors.

Curr Cancer Drug Targets 2011 Jul;11(6):688-97

HELIOS Klinikum Bad Saarow, Department of Hematology, Oncology and Palliative Care, Sarcoma Center Berlin-Brandenburg, Pieskower Strasse 33, 15526 Bad Saarow, Germany.

View Article and Find Full Text PDF
July 2011

Clinical experience to date with nilotinib in gastrointestinal stromal tumors.

Semin Oncol 2011 Apr;38 Suppl 1:S20-7

Department of Hematology, Oncology and Palliative Medicine, HELIOS Klinikum, Bad Saarow, Germany.

View Article and Find Full Text PDF
April 2011

Sphingosine 1-phosphate-induced motility and endocytosis of dendritic cells is regulated by SWAP-70 through RhoA.

J Immunol 2011 May 18;186(9):5345-55. Epub 2011 Mar 18.

Faculty of Medicine Carl Gustav Carus, Institute of Physiological Chemistry, Dresden University of Technology, D-01307 Dresden, Germany.

View Article and Find Full Text PDF
May 2011

Response to nilotinib as a first-line treatment for metastatic gastrointestinal stromal tumors.

J Gastrointest Cancer 2012 Jun;43(2):385-7

Department of Internal Medicine III-Hematology/Oncology, University Hospital Munich-Campus Grosshadern, Munich, Germany.

View Article and Find Full Text PDF
June 2012

Practical management of tyrosine kinase inhibitor-associated side effects in GIST.

Cancer Treat Rev 2011 Feb 31;37(1):75-88. Epub 2010 May 31.

Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland.

View Article and Find Full Text PDF
February 2011

Optimal use of targeted agents for advanced gastrointestinal stromal tumours.

Authors:
Peter Reichardt

Oncology 2010 13;78(2):130-40. Epub 2010 Apr 13.

HELIOS Klinikum Bad Saarow, Bad Saarow, Germany.

View Article and Find Full Text PDF
May 2010

Osteosarcoma: the COSS experience.

Cancer Treat Res 2009 ;152:289-308

Pädiatrie 5 (Onkologie, Hämatologie,Immunologie), Klinikum Stuttgart, Zentrum für Kinder- und Jugendmedizin-Olgahospital, Bismarckstr. 8, D-70176, Stuttgart, Germany.

View Article and Find Full Text PDF
October 2010

Towards global consensus in the treatment of gastrointestinal stromal tumor.

Expert Rev Anticancer Ther 2010 Feb;10(2):221-32

Department of Hematology, Oncology and Palliative Medicine, HELIOS Klinikum Bad Saarow, Pieskower Strasse 33, D-15526 Bad Saarow, Germany.

View Article and Find Full Text PDF
February 2010

APC, T cells, and the immune synapse.

Curr Top Microbiol Immunol 2010 ;340:229-49

Otto-von-Guericke University, Institute of Molecular and Clinical Immunology, D-39120, Magdeburg, Germany.

View Article and Find Full Text PDF
April 2010

Imaging immunity.

Eur J Immunol 2009 Dec;39(12):3279-82

Otto von Guericke University Magdeburg, Institute for Molecular and Clinical Immunology, Magdeburg, Germany.

View Article and Find Full Text PDF
December 2009